New Users of Herbal Medicine Containing Aristolochic Acids and the Risk of Dementia in the Elderly: A Nationwide, Population-Based Study in Taiwan

Yueh-Er Chiou,1,2 Wu-Chien Chien,3– 5,* Chi-Hsiang Chung,3,4,6 Hsin-An Chang,7,8 Yu-Chen Kao,7,9 Pei-Kwei Tsay,10,* Nian-Sheng Tzeng7,8,* 1Department of Nursing, College of Medicine, Fu Jen Catholic University, New Taipei City, Taiwan; 2Graduate Institute of Clinical Medical Sciences, Coll...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Chiou YE, Chien WC, Chung CH, Chang HA, Kao YC, Tsay PK, Tzeng NS
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2020
Materias:
Acceso en línea:https://doaj.org/article/c3838a1ed2e946729108f927c2f28410
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:c3838a1ed2e946729108f927c2f28410
record_format dspace
institution DOAJ
collection DOAJ
language EN
topic herbal medicine containing aristolochic acids
traditional chinese herbal medicines
dementia
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
spellingShingle herbal medicine containing aristolochic acids
traditional chinese herbal medicines
dementia
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
Chiou YE
Chien WC
Chung CH
Chang HA
Kao YC
Tsay PK
Tzeng NS
New Users of Herbal Medicine Containing Aristolochic Acids and the Risk of Dementia in the Elderly: A Nationwide, Population-Based Study in Taiwan
description Yueh-Er Chiou,1,2 Wu-Chien Chien,3– 5,* Chi-Hsiang Chung,3,4,6 Hsin-An Chang,7,8 Yu-Chen Kao,7,9 Pei-Kwei Tsay,10,* Nian-Sheng Tzeng7,8,* 1Department of Nursing, College of Medicine, Fu Jen Catholic University, New Taipei City, Taiwan; 2Graduate Institute of Clinical Medical Sciences, College of Medicine, Chang Gung University, Tao-Yuan, Taiwan; 3Department of Medical Research, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan; 4School of Public Health, National Defense Medical Center, Taipei, Taiwan; 5Graduate Institute of Life Sciences, National Defense Medical Center, Taipei, Taiwan; 6Taiwanese Injury Prevention and Safety Promotion Association, Taipei, Taiwan; 7Department of Psychiatry, Tri-Service General Hospital, School of Medicine, National Defense Medical Center, Taipei, Taiwan; 8Student Counseling Center, National Defense Medical Center, Taipei, Taiwan; 9Department of Psychiatry, Tri-Service General Hospital, Song-Shan Branch, National Defense Medical Center, Taipei, Taiwan; 10Department of Public Health and Center of Biostatistics, College of Medicine, Chang Gung University, Tao-Yuan 333, Taiwan*These authors contributed equally to this workCorrespondence: Pei-Kwei TsayDepartment of Public Health and Center of Biostatistics, College of Medicine, Chang Gung University, Tao-Yuan 333, TaiwanTel +886-3-211-8800 # 5068 (PKT)Email Tsay@mail.cgu.edu.twNian-Sheng TzengJoint Program for Geriatric Psychiatry and Psychosomatic Medicine, Department of Psychiatry, School of Medicine, Tri-Service General Hospital, National Defense Medical Center, 325, Section 2, Cheng-Gung Road, Nei-Hu District, Taipei, Taiwan, Republic of ChinaTel +886-2-87923311, Ext 17484Fax +886-2-87927221Email pierrens@mail.ndmctsgh.edu.twBackground: Herbal medicine containing aristolochic acids (HMCAA) was used for inflammatory and infectious diseases. This study aimed to investigate the association between the usage of HMCAA and the risk of dementia.Methods: A total of 199 new users of HMCAA were enrolled, along with 597 controls without the usage of HMCAA, at a ratio of 1:3 – matched by age, sex, and comorbidity, between 2000 and 2003 – from the National Health Research Institutes Database (NHRID) of Taiwan, which contains two million randomly sampled subjects, in this cohort study. We used Fine and Gray’s survival analysis (competing with mortality) to compare the risk of developing dementia during a 15-year follow-up period (2000– 2015).Results: In general, HMCAA was not significantly associated with dementia (adjusted subdistribution hazard ratio [SHR] = 0.861, 95% confidence interval [CI] = 0.484– 1.532, p = 0.611) for the HMCAA-cohort, although differential risk was observed among the groups at risk. The patients with usage of HMCAA aged ≧ 85 years were associated with a higher risk in dementia (adjusted SHR: 6.243, 95% CI=1.258– 21.084, p = 0.001), in comparison to those aged 50– 54 years. Furthermore, the patients with usage of HMCAA that had cerebrovascular accidents were associated with an increased risk of dementia.Conclusion: The usage of HMCAA was associated with the risk of developing dementia in the patients aged ≧ 85 years.Keywords: herbal medicine containing aristolochic acids, traditional Chinese herbal medicines, dementia
format article
author Chiou YE
Chien WC
Chung CH
Chang HA
Kao YC
Tsay PK
Tzeng NS
author_facet Chiou YE
Chien WC
Chung CH
Chang HA
Kao YC
Tsay PK
Tzeng NS
author_sort Chiou YE
title New Users of Herbal Medicine Containing Aristolochic Acids and the Risk of Dementia in the Elderly: A Nationwide, Population-Based Study in Taiwan
title_short New Users of Herbal Medicine Containing Aristolochic Acids and the Risk of Dementia in the Elderly: A Nationwide, Population-Based Study in Taiwan
title_full New Users of Herbal Medicine Containing Aristolochic Acids and the Risk of Dementia in the Elderly: A Nationwide, Population-Based Study in Taiwan
title_fullStr New Users of Herbal Medicine Containing Aristolochic Acids and the Risk of Dementia in the Elderly: A Nationwide, Population-Based Study in Taiwan
title_full_unstemmed New Users of Herbal Medicine Containing Aristolochic Acids and the Risk of Dementia in the Elderly: A Nationwide, Population-Based Study in Taiwan
title_sort new users of herbal medicine containing aristolochic acids and the risk of dementia in the elderly: a nationwide, population-based study in taiwan
publisher Dove Medical Press
publishDate 2020
url https://doaj.org/article/c3838a1ed2e946729108f927c2f28410
work_keys_str_mv AT chiouye newusersofherbalmedicinecontainingaristolochicacidsandtheriskofdementiaintheelderlyanationwidepopulationbasedstudyintaiwan
AT chienwc newusersofherbalmedicinecontainingaristolochicacidsandtheriskofdementiaintheelderlyanationwidepopulationbasedstudyintaiwan
AT chungch newusersofherbalmedicinecontainingaristolochicacidsandtheriskofdementiaintheelderlyanationwidepopulationbasedstudyintaiwan
AT changha newusersofherbalmedicinecontainingaristolochicacidsandtheriskofdementiaintheelderlyanationwidepopulationbasedstudyintaiwan
AT kaoyc newusersofherbalmedicinecontainingaristolochicacidsandtheriskofdementiaintheelderlyanationwidepopulationbasedstudyintaiwan
AT tsaypk newusersofherbalmedicinecontainingaristolochicacidsandtheriskofdementiaintheelderlyanationwidepopulationbasedstudyintaiwan
AT tzengns newusersofherbalmedicinecontainingaristolochicacidsandtheriskofdementiaintheelderlyanationwidepopulationbasedstudyintaiwan
_version_ 1718396852897841152
spelling oai:doaj.org-article:c3838a1ed2e946729108f927c2f284102021-12-02T10:41:22ZNew Users of Herbal Medicine Containing Aristolochic Acids and the Risk of Dementia in the Elderly: A Nationwide, Population-Based Study in Taiwan1178-2021https://doaj.org/article/c3838a1ed2e946729108f927c2f284102020-06-01T00:00:00Zhttps://www.dovepress.com/new-users-of-herbal-medicine-containing-aristolochic-acids-and-the-ris-peer-reviewed-article-NDThttps://doaj.org/toc/1178-2021Yueh-Er Chiou,1,2 Wu-Chien Chien,3– 5,* Chi-Hsiang Chung,3,4,6 Hsin-An Chang,7,8 Yu-Chen Kao,7,9 Pei-Kwei Tsay,10,* Nian-Sheng Tzeng7,8,* 1Department of Nursing, College of Medicine, Fu Jen Catholic University, New Taipei City, Taiwan; 2Graduate Institute of Clinical Medical Sciences, College of Medicine, Chang Gung University, Tao-Yuan, Taiwan; 3Department of Medical Research, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan; 4School of Public Health, National Defense Medical Center, Taipei, Taiwan; 5Graduate Institute of Life Sciences, National Defense Medical Center, Taipei, Taiwan; 6Taiwanese Injury Prevention and Safety Promotion Association, Taipei, Taiwan; 7Department of Psychiatry, Tri-Service General Hospital, School of Medicine, National Defense Medical Center, Taipei, Taiwan; 8Student Counseling Center, National Defense Medical Center, Taipei, Taiwan; 9Department of Psychiatry, Tri-Service General Hospital, Song-Shan Branch, National Defense Medical Center, Taipei, Taiwan; 10Department of Public Health and Center of Biostatistics, College of Medicine, Chang Gung University, Tao-Yuan 333, Taiwan*These authors contributed equally to this workCorrespondence: Pei-Kwei TsayDepartment of Public Health and Center of Biostatistics, College of Medicine, Chang Gung University, Tao-Yuan 333, TaiwanTel +886-3-211-8800 # 5068 (PKT)Email Tsay@mail.cgu.edu.twNian-Sheng TzengJoint Program for Geriatric Psychiatry and Psychosomatic Medicine, Department of Psychiatry, School of Medicine, Tri-Service General Hospital, National Defense Medical Center, 325, Section 2, Cheng-Gung Road, Nei-Hu District, Taipei, Taiwan, Republic of ChinaTel +886-2-87923311, Ext 17484Fax +886-2-87927221Email pierrens@mail.ndmctsgh.edu.twBackground: Herbal medicine containing aristolochic acids (HMCAA) was used for inflammatory and infectious diseases. This study aimed to investigate the association between the usage of HMCAA and the risk of dementia.Methods: A total of 199 new users of HMCAA were enrolled, along with 597 controls without the usage of HMCAA, at a ratio of 1:3 – matched by age, sex, and comorbidity, between 2000 and 2003 – from the National Health Research Institutes Database (NHRID) of Taiwan, which contains two million randomly sampled subjects, in this cohort study. We used Fine and Gray’s survival analysis (competing with mortality) to compare the risk of developing dementia during a 15-year follow-up period (2000– 2015).Results: In general, HMCAA was not significantly associated with dementia (adjusted subdistribution hazard ratio [SHR] = 0.861, 95% confidence interval [CI] = 0.484– 1.532, p = 0.611) for the HMCAA-cohort, although differential risk was observed among the groups at risk. The patients with usage of HMCAA aged ≧ 85 years were associated with a higher risk in dementia (adjusted SHR: 6.243, 95% CI=1.258– 21.084, p = 0.001), in comparison to those aged 50– 54 years. Furthermore, the patients with usage of HMCAA that had cerebrovascular accidents were associated with an increased risk of dementia.Conclusion: The usage of HMCAA was associated with the risk of developing dementia in the patients aged ≧ 85 years.Keywords: herbal medicine containing aristolochic acids, traditional Chinese herbal medicines, dementiaChiou YEChien WCChung CHChang HAKao YCTsay PKTzeng NSDove Medical Pressarticleherbal medicine containing aristolochic acidstraditional chinese herbal medicinesdementiaNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571Neurology. Diseases of the nervous systemRC346-429ENNeuropsychiatric Disease and Treatment, Vol Volume 16, Pp 1493-1504 (2020)